Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin E Deverman

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 11, 2012
Exogenous leukemia inhibitory factor stimulates oligodendrocyte progenitor cell proliferation and enhances hippocampal remyelinationBenjamin E Deverman, Paul H Patterson
Neuron|October 21, 2009
Cytokines and CNS developmentBenjamin E Deverman, Paul H Patterson
Science'S STKE : Signal Transduction Knowledge Environment|October 25, 2007
Chronoregulation by asparagine deamidationSteven J Weintraub, Benjamin E Deverman
Annual Review of Neuroscience|May 1, 2018
Viral Strategies for Targeting the Central and Peripheral Nervous SystemsClaire N Bedbrook, Benjamin E Deverman, Viviana Gradinaru
Cancer Cell|January 30, 2004
Resistance to antineoplastic therapy. The oncogenic tyrosine kinase-Bcl-x(L) axisSteven J Weintraub, Scott R Manson, Benjamin E Deverman
Frontiers in Molecular Neuroscience|November 22, 2016
Better Targeting, Better Efficiency for Wide-Scale Neuronal Transduction with the Synapsin Promoter and AAV-PHP.BKasey L Jackson, Robert D Dayton, Benjamin E Deverman, et al.
Frontiers in Molecular Neuroscience|December 24, 2016
Corrigendum: Better Targeting, Better Efficiency for Wide-Scale Neuronal Transduction with the Synapsin Promoter and AAV-PHP.BKasey L Jackson, Robert D Dayton, Benjamin E Deverman, et al.
Elife|February 23, 2021
COVID-19 CG enables SARS-CoV-2 mutation and lineage tracking by locations and dates of interestAlbert Tian Chen, Kevin Altschuler, Shing Hei Zhan, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2020
COVID-19 CG: Tracking SARS-CoV-2 mutations by locations and dates of interestAlbert Tian Chen, Kevin Altschuler, Shing Hei Zhan, et al.
Nature Reviews. Drug Discovery|September 13, 2018
Gene therapy for neurological disorders: progress and prospectsBenjamin E Deverman, Bernard M Ravina, Krystof S Bankiewicz, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 11, 2012
Exogenous leukemia inhibitory factor stimulates oligodendrocyte progenitor cell proliferation and enhances hippocampal remyelinationBenjamin E Deverman, Paul H Patterson
Neuron|October 21, 2009
Cytokines and CNS developmentBenjamin E Deverman, Paul H Patterson
Science'S STKE : Signal Transduction Knowledge Environment|October 25, 2007
Chronoregulation by asparagine deamidationSteven J Weintraub, Benjamin E Deverman
Annual Review of Neuroscience|May 1, 2018
Viral Strategies for Targeting the Central and Peripheral Nervous SystemsClaire N Bedbrook, Benjamin E Deverman, Viviana Gradinaru
Cancer Cell|January 30, 2004
Resistance to antineoplastic therapy. The oncogenic tyrosine kinase-Bcl-x(L) axisSteven J Weintraub, Scott R Manson, Benjamin E Deverman
Frontiers in Molecular Neuroscience|November 22, 2016
Better Targeting, Better Efficiency for Wide-Scale Neuronal Transduction with the Synapsin Promoter and AAV-PHP.BKasey L Jackson, Robert D Dayton, Benjamin E Deverman, et al.
Frontiers in Molecular Neuroscience|December 24, 2016
Corrigendum: Better Targeting, Better Efficiency for Wide-Scale Neuronal Transduction with the Synapsin Promoter and AAV-PHP.BKasey L Jackson, Robert D Dayton, Benjamin E Deverman, et al.
Elife|February 23, 2021
COVID-19 CG enables SARS-CoV-2 mutation and lineage tracking by locations and dates of interestAlbert Tian Chen, Kevin Altschuler, Shing Hei Zhan, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2020
COVID-19 CG: Tracking SARS-CoV-2 mutations by locations and dates of interestAlbert Tian Chen, Kevin Altschuler, Shing Hei Zhan, et al.
Nature Reviews. Drug Discovery|September 13, 2018
Gene therapy for neurological disorders: progress and prospectsBenjamin E Deverman, Bernard M Ravina, Krystof S Bankiewicz, et al.
Pageof 5